ETFs
K
KNSA
Kiniksa Pharmaceuticals Internat…
48.42
-0.81-1.65%After Hours: 47.66 -0.76 -1.57%19:53 06/05 EDT
OPEN/PREV CLOSE49.20/49.27
TODAY RANGE48.71-51.64
VOL15
MARKET CAP3.97B
52 WEEK RANGE26.27-59.87
AVG VOL (3M)672.99K
% TURNOVER0.81%
TURNOVER0
P/E (TTM)56.89
% RANGE5.96%
EPS(TTM)0.9067
P/E(FORWARD)42.28
P/B6.55
BVPS7.87
DIVIDEND--
P/S5.81
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.29B
SHARES OUTSTANDING76.94M
NEXT EARNINGS07/27-07/31
FREE FLOAT44.44M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/29 21:55
Kiniksa Shareholders Reelect Directors and Approve Auditor Mandates
PUBT·05/29 20:36
Kiniksa Pharmaceuticals held annual shareholder meeting
TipRanks·05/26 22:09
Kiniksa Pharmaceuticals Caps Major Shareholder Voting Control Rights
PUBT·05/08 17:30
Kiniksa Pharmaceuticals announces annual shareholder meeting
PUBT·05/08 17:30
Kiniksa publishes 2025 annual report
Simply Wall St·05/06 03:30
Why Kiniksa Pharmaceuticals (KNSA) Is Up 5.4% After Raising 2026 Revenue Guidance And What's Next
Simply Wall St·05/05 01:33
Assessing Kiniksa Pharmaceuticals (KNSA) Valuation After Strong Q1 Results And Raised Revenue Guidance
TipRanks·05/01 21:55
Kiniksa Pharmaceuticals CSO Resigns and Shifts to Advisor
PUBT·05/01 20:33
Kiniksa CEO Sanj K Patel sells shares worth $2.62 million
Simply Wall St·04/30 15:12
Is It Too Late To Consider Kiniksa Pharmaceuticals (KNSA) After Its 91% One-Year Surge?
Same Industry
Name/Symbol
Change%
Price